Acute traumatic haemorrhagic shock and transfusion: What's new in 2009?;Prise en charge transfusionnelle du choc hémorragique d'origine traumatique à la phase aiguë : quoi de neuf en 2009 ?

Annales Francaises d'Anesthesie et de Reanimation

Volumn 28, Issue 3, 2009, Pages 222-230

  Morel, N ^a   Morel, O ^b   Chimot, L ^a   Lortet, V ^a   Julliac, B ^a   Lelias, A ^a   Merson, L ^a   Dabadie, Ph ^a  

^a HÔPITAL PELLEGRIN   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Haemorrhagic shock; Transfuse; Traumatology

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CAUSE OF DEATH; ERYTHROCYTE; HEMORRHAGIC SHOCK; HEMOSTASIS; HUMAN; HYPOTHERMIA; INJURY; LEUKOCYTE; METABOLIC ACIDOSIS; PLATELET MICROPARTICLE; PREDICTION; PROGNOSIS; SHORT SURVEY; THROMBOCYTE TRANSFUSION; TRAUMATOLOGY;

ACIDOSIS; ACUTE DISEASE; ANOXIA; ANTIGENS; BLOOD COAGULATION DISORDERS; BLOOD TRANSFUSION; BLOOD VOLUME; COMBINED MODALITY THERAPY; EMERGENCY MEDICAL SERVICES; FACTOR VII; HUMANS; HYPOTENSION; HYPOTHERMIA; RECOMBINANT PROTEINS; SHOCK, HEMORRHAGIC; TIME FACTORS; WOUNDS AND INJURIES;

EID: 64049096537     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2008.12.023     Document Type: Short Survey

References (41)

1. Lienhart A., Auroy Y., Pequignot F., Benhamou D., Warszawski J., Bovet M., et al. Survey of anesthesia-related mortality in France. Anesthesiology 105 (2006) 1087-1097
2. Orfeo T., Butenas S., Brummel-Ziedins K.E., and Mann K.G. The tissue factor requirement in blood coagulation. J Biol Chem 280 (2005) 42887-42896
3. Mann K.G., van't Veer C., Cawthern K., and Butenas S. The role of the tissue factor pathway in initiation of coagulation. Blood Coagul Fibrinolysis 9 (1998) S3-S7
4. Ruf W., Kalnik M.W., Lund-Hansen T., and Edgington T.S. Characterization of factor VII association with tissue factor in solution. High and low affinity calcium binding sites in factor VII contribute to functionally distinct interactions. J Biol Chem 266 (1991) 15719-15725
5. Bevers E.M., Comfurius P., van Rijn J.L., Hemker H.C., and Zwaal R.F. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 122 (1982) 429-436
6. Butenas S., Branda R.F., van't Veer C., Cawthern K.M., and Mann K.G. Platelets and phospholipids in tissue factor-initiated thrombin generation. Thromb Haemost 86 (2001) 660-667
7. Rosing J., Tans G., Govers-Riemslag J.W., Zwaal R.F., and Hemker H.C. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 255 (1980) 274-283
8. Gilbert G.E., and Drinkwater D. Specific membrane binding of factor VIII is mediated by O-phospho-L-serine, a moiety of phosphatidylserine. Biochemistry 32 (1993) 9577-9585
9. Morel N., Morel O., Delabranche X., Jesel L., Sztark F., Dabadie P., et al. Microparticules circulantes au cours des traumatismes graves et des sepsis : un élément du couplage inflammation-thrombose. Ann Fr Anesth Reanim 25 (2006) 955-966
10. Horne III M.K., Cullinane A.M., Merryman P.K., and Hoddeson E.K. The effect of red blood cells on thrombin generation. Br J Haematol 133 (2006) 403-408
11. Kempe D.S., Akel A., Lang P.A., Hermle T., Biswas R., Muresanu J., et al. Suicidal erythrocyte death in sepsis. J Mol Med (2006)
12. Francischetti I.M., Seydel K.B., Monteiro R.Q., Whitten R.O., Erexson C.R., Noronha A.L., et al. Plasmodium falciparum-infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexes. J Thromb Haemost (2006)
13. Berezina T.L., Zaets S.B., Kozhura V.L., Novoderzhkina I.S., Kirsanova A.K., Deitch E.A., et al. Morphologic changes of red blood cells during haemorrhagic shock replicate changes of aging. Shock 15 (2001) 467-470
14. Hrachovinova I., Cambien B., Hafezi-Moghadam A., Kappelmayer J., Camphausen R.T., Widom A., et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct haemostasis in a mouse model of haemophilia A. Nat Med 9 (2003) 1020-1025
15. Falati S., Liu Q., Gross P., Merrill-Skoloff G., Chou J., Vandendries E., et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 197 (2003) 1585-1598
16. Brohi K., Singh J., Heron M., and Coats T. Acute traumatic coagulopathy. J Trauma 54 (2003) 1127-1130
17. Bonnemaison J., Thicoïpé M., Dixmerias F., and Guerin V. Coagulopathie évocatrice d'une fibrinolyse primaire après traumatisme crânien compliquée de mort cérébrale. Ann Fr Anesth Reanim 17 (1998) 275-277
18. Nekludov M., Bellander B.M., Blomback M., and Wallen H.N. Platelet dysfunction in patients with severe traumatic brain injury. J Neurotrauma 24 (2007) 1699-1706
19. MacLeod J.B., Lynn M., McKenney M.G., Cohn S.M., and Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma 55 (2003) 39-44
20. Ho A.M., Karmakar M.K., and Dion P.W. Are we giving enough coagulation factors during major trauma resuscitation?. Am J Surg 190 (2005) 479-484
21. Watts D.D., Trask A., Soeken K., Perdue P., Dols S., and Kaufmann C. Hypothermic coagulopathy in trauma: effect of varying levels of hypothermia on enzyme speed, platelet function and fibrinolytic activity. J Trauma 44 (1998) 846-854
22. Martini W.Z., Pusateri A.E., Uscilowicz J.M., Delgado A.V., and Holcomb J.B. Independent contributions of hypothermia and acidosis to coagulopathy in swine. J Trauma 58 (2005) 1002-1009 [discussion 1009-10]
23. Renckens R., Roelofs J.J., de Waard V., Florquin S., Lijnen H.R., Carmeliet P., et al. The role of plasminogen activator inhibitor type 1 in the inflammatory response to local tissue injury. J Thromb Haemost 3 (2005) 1018-1025
24. Jacoby R.C., Owings J.T., Holmes J., Battistella F.D., Gosselin R.C., and Paglieroni T.G. Platelet activation and function after trauma. J Trauma 51 (2001) 639-647
25. Samama M. Coagulopathie dans le sepsis sévère : y a-t-il du nouveau ?. Ann Fr Anesth Reanim 22 (2003) 34-35
26. Gando S., Nakanishi Y., and Tedo I. Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome. Crit Care Med 23 (1995) 1835-1842
27. Smail N., Descorps-Declère A., Duranteau J., Vigué B., and Samii K. Left ventricular function after severe trauma. Intensive Care Med 22 (1996) 439-442
28. Smith M.J., Stiefel M.F., Magge S., Frangos S., Bloom S., Gracias V., et al. Packed red blood cell transfusion increases local cerebral oxygenation. Crit Care Med 33 (2005) 1104-1108
29. Agence française de sécurité sanitaire des produits de santé (Afssaps). Transfusion of erythrocyte substitutes: products, indications, alternatives. General methods and recommendations. Transfus Clin Biol 2002;9:333-56.
30. Stern S.A., Dronen S.C., Birrer P., and Wang X. Effect of blood pressure on haemorrhage volume and survival in a near-fatal haemorrhage model incorporating a vascular injury. Ann Emerg Med 22 (1993) 155-163
31. Bickell W.H., Wall Jr. M.J., Pepe P.E., Martin R.R., Ginger V.F., Allen M.K., et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 331 (1994) 1105-1109
32. Dutton R.P., Mackenzie C.F., and Scalea T.M. Hypotensive resuscitation during active haemorrhage: impact on in-hospital mortality. J Trauma 52 (2002) 1141-1146
33. Hebert P.C., Wells G., Blajchman M.A., Marshall J., Martin C., Pagliarello G., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators. N Engl J Med 340 (1999) 409-417
34. Spahn D.R., and Rossaint R. Coagulopathy and blood component transfusion in trauma. Br J Anaesth 95 (2005) 130-139
35. Simmons R.L., Collins J.A., Heisterkamp C.A., Mills D.E., Andren R., and Phillips L.L. Coagulation disorders in combat casualties. I. Acute changes after wounding. II. Effects of massive transfusion. III. Post-resuscitative changes. Ann Surg 169 (1969) 455-482
36. Dutton R.P., Stein D.M., Hess J.R., and Scalea T.M. Recombinant factor VIIa and thromboembolic events. JAMA 296 (2006) 43-44 [author reply 44]
37. Samama C.M., Djoudi R., Lecompte T., Nathan-Denizot N., and Schved J.F. Perioperative platelet transfusion: recommendations of the Agence française de sécurité sanitaire des produits de santé (Afssaps) 2003. Can J Anaesth 52 (2005) 30-37
38. Cauwenberghs S., Feijge M.A., Harper A.G., Sage S.O., Curvers J., and Heemskerk J.W. Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilization of actin cytoskeleton. FEBS Lett 580 (2006) 5313-5320
39. Boffard K.D., Riou B., Warren B., Choong P.I., Rizoli S., Rossaint R., et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59 (2005) 8-15 [discussion 15-8]
40. Rizoli S.B., Boffard K.D., Riou B., Warren B., Iau P., Kluger Y., et al. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials. Crit Care 10 (2006) R178
41. Vincent J.L., Rossaint R., Riou B., Ozier Y., Zideman D., and Spahn D.R. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding. A European perspective. Crit Care 10 (2006) R120